Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 111

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 111
---
 this prospectus, after deducting assumed underwriting discounts and commissions and estimated offering expenses) immediately following the completion of this offering, we would recognize an incremental deferred tax asset of approximately $ and a non-currentliability of approximately $ based on the Company’s estimate of the aggregate amount that it will pay under the tax receivable agreement as a result of such future exchanges, utilizing various assumptions set forth in the Tax Receivable Agreement, including without limitation the following: (i) a price of $ per share (the assumed initial public offering price, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus); (ii) a constant combined federal and state corporate tax rate of %; (iii) we will have sufficient taxable income to fully utilize the tax benefits; and (iv) no material changes in tax law. These amounts are estimates and have been prepared for informational purposes only. The actual amount of deferred tax assets and related non-currentliabilities that we will recognize as a result of any such future exchanges will differ based on, among other things: (i) the amount and timing of future exchanges of LGN Units by LGN Unit Holders (including any LGN Units issued upon conversion of vested Series A Profits Interests), and the extent to which such exchanges are taxable; (ii) the price per share of our Class A Common Stock at the time of the exchanges; (iii) the amount and timing of future income against which to offset the tax benefits; and (iv) the tax rates then in effect.

| d) | Represents (i) the net proceeds of approximately $    based on an assumed initial                                                                                                                                                 
 public offering price of $    per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting assumed underwriting discounts and commissions and estimated 
 offering expenses and (ii) the related use of $    of the proceeds to repay outstanding indebtedness under our Term Loan Credit Facility, as will be determined prior to the offering, and $    of                                
 the proceeds for general corporate purposes as described in “Use of Proceeds.”                                                                                                                                                    |

3. Notes to Unaudited Pro Forma Condensed Consolidated Statement of Operations Transaction accounting adjustments include the following adjustments related to the unaudited pro forma condensed consolidated statement of operations for the year ended December 31,